Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant
Clinical trial NCT05317416 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05317416
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-25
- Primary completion
- 2027-08-04
- Enrollment
- 854
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.